Redigerer Jon Sudbø (avsnitt)

== Publikasjoner ==
Artikkelpublikasjonene omfatter vitenskapelige artikler, oversiktsartikler og kortere arbeider publisert i vitenskapelige tidsskrifter.

=== Doktorgradsavhandling ===
* Sudbø J. 2001. ''Predictive markers in oral premalignancies and early stage carcinomas''. Oslo : Department of Pathology, The Norwegian Radium Hospital. ISBN 82-7633-163-7. Doktorgradsavhandling i medisin, Universitetet i Oslo.
** '''Tilbaketrekking: Avhandlingen underkjent og graden frakjent desember 2006'''

=== Artikler som ble trukket tilbake ===
<div style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
* Sudbø J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimäki A, Sudbø A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. ''[[The Lancet|Lancet]]''. 2005 Oct 15-21;366(9494):1359-66.
** '''Tilbaketrekking: Horton R. ''[[The Lancet|Lancet]]''. 2006 Feb 4;367(9508):382.'''
* Sudbø J. Novel management of oral cancer: a paradigm of predictive oncology. ''Clin Med Res.'' 2004 Nov;2(4):233-42. Review.
** '''Tilbaketrekking: Reed KD, Salzman-Scott SA. ''Clin Med Res.'' 2007 Oct;5(3):203.'''
* Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A. Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling. ''J Clin Oncol.'' 2005 Mar 20;23(9):1927-33.
** '''Tilbaketrekking: ''J Clin Oncol.'' 2006 Dec 10;24(35):5621.'''
* Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy on mortality in oral leukoplakia. ''[[The New England Journal of Medicine|N Engl J Med.]]'' 2004 Apr 1;350(14):1405-13.
** '''Tilbaketrekking: Curfman GD, Morrissey S, Drazen JM. ''N Engl J Med.'' 2006 Nov 2;355(18):1927.'''
* Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. Molecular based treatment of oral cancer. ''Oral Oncol.'' 2003 Dec;39(8):749-58. Review.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):421.'''
* Sudbø J. [Chemoprevention of oral cancer]. ''Tidsskr Nor Laegeforen.'' 2003 May 29;123(11):1518-21. Review.
** '''Tilbaketrekking: Haug C. ''Tidsskr Nor Laegeforen.'' 2006 Sep 7;126(17):2287.'''
* Sudbø J, Ristimäki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. ''Oral Oncol.'' 2003 Jul;39(5):497-505.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):420.'''
* Sudbø J, Reith A. When is an oral leukoplakia premalignant? ''Oral Oncol.'' 2002 Dec;38(8):813-4.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):419.'''
* Sudbø J, Warloe T, Aamdal S, Reith A, Bryne M. [Diagnosis and treatment of oral precancerous lesions]. ''Tidsskr Nor Laegeforen.'' 2001 Oct 30;121(26):3066-71.
** '''Tilbaketrekking: Warloe T, Aamdal S, Reith A, Bryne M. ''Tidsskr Nor Laegeforen.'' 2006 Sep 7;126(17):2287.'''
* Sudbø J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. ''Oral Oncol.'' 2001 Oct;37(7):558-65.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):418.'''
* Sudbø J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. ''J Pathol.'' 2001 Jul;194(3):303-10.
** '''Tilbaketrekking: ''J Pathol.'' 2007 Jan;211(1):109.'''
* Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. ''N Engl J Med.'' 2001 Apr 26;344(17):1270-8.
** '''Tilbaketrekking: Curfman GD, Morrissey S, Drazen JM. ''N Engl J Med.'' 2006 Nov 2;355(18):1927.'''
</div>

=== Artikler som ikke er trukket tilbake ===
<div style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
* Kildal W, Risberg B, Abeler VM, Kristensen GB, Sudbø J, Nesland JM, Danielsen HE. Beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. ''Eur J Cancer.'' 2005 May;41(8):1127-34.
* Lilleby W, Sudbø J, Fosså SD. Biology and treatment options during the development of prostate cancer. ''Tidsskr Nor Laegeforen.'' 2005 Mar 3;125(5):571-4. Review.
* Sudbø J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. ''Int J Cancer.'' 2005 Jun 20;115(3):339-45. Review.
* Lippman SM, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. ''J Clin Oncol.'' 2005 Jan 10;23(2):346-56. Review.
* Kildal W, Kaern J, Kraggerud SM, Abeler VM, Sudbø J, Tropè CG, Lothe RA, Danielsen HE. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables. ''Cancer Genet Cytogenet.'' 2004 Nov;155(1):25-32.
* Sudbø J. Non-invasive early diagnosis of oral cavity malignancies. ''Anal Cell Pathol.'' 2003;25(4):157-8. 
* Sudbø J. [Chemoprevention: treatment of persons at high risk of cancer]. ''Tidsskr Nor Laegeforen.'' 2003 May 29;123(11):1514-7. Review.
* Scully C, Sudbø J, Speight PM. Progress in determining the malignant potential of oral lesions. ''J Oral Pathol Med.'' 2003 May;32(5):251-6. Review.
* Sudbø J, Reith A. Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. ''J Oral Pathol Med.'' 2003 Feb;32(2):63-70. Review.
* Reith A, Sudbø J. Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies. ''Int J Cancer.'' 2002 Sep 20;101(3):205-9. Review.
* Sudbø J. [Adverse effects of COX-2 inhibitors]. ''Tidsskr Nor Laegeforen.'' 2002 Jan 10;122(1):102-3.
* Sudbø J. [DNA ploidy analysis--a possibility for early identification of patient with risk of oral cancer]. ''Lakartidningen.'' 2001 Nov 7;98(45):4980-4. Review. 
* Sudbø J. Pathology in disgrace? ''J Pathol.'' 2002 Feb;196(2):244-5.
* Sudbø J, Kildal W, Johannessen AC, Koppang HS, Sudbø A, Danielsen HE, Risberg B, Reith A. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. ''J Clin Oncol.'' 2002 Jan 15;20(2):456-62.
* Sudbø J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. ''N Engl J Med.'' 2001 Aug 2;345(5):376-7.
* Sudbø J, Reith A, Lingjaerde OC. Gene-expression profiles in hereditary breast cancer. ''N Engl J Med.'' 2001 Jun 28;344(26):2029.
* Sudbø J, Marcelpoil R, Reith A. New algorithms based on the Voronoi Diagram applied in a pilot study on normal mucosa and carcinomas. ''Anal Cell Pathol.'' 2000;21(2):71-86.
* Sudbø J, Marcelpoil R, Reith A. Caveats: numerical requirements in graph theory based quantitation of tissue architecture. ''Anal Cell Pathol.'' 2000;21(2):59-69.
* Sudbø J, Bankfalvi A, Bryne M, Marcelpoil R, Boysen M, Piffko J, Hemmer J, Kraft K, Reith A. Prognostic value of graph theory-based tissue architecture analysis in carcinomas of the tongue. ''Lab Invest.'' 2000 Dec;80(12):1881-9.
* Danielsen HE, Kildal W, Sudbø J. [Digital image analysis in pathology--exemplified in prostatic cancer]. ''Tidsskr Nor Laegeforen.'' 2000 Feb 10;120(4):479-88. Review. 
* Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A. The invasive front of carcinomas. The most important area for tumour prognosis? ''Anticancer Res.'' 1998 Nov-Dec;18(6B):4757-64. Review.
* Zhang Z, Suo Z, Sudbø J, Holm R, Boysen M, Reith A. Diagnostic implications of p53 protein reactivity in nasal mucosa of nickel workers. ''Anal Quant Cytol Histol.'' 1997 Aug;19(4):345-50.
* Xie X, Clausen OP, Sudbø J, Boysen M. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. ''Cancer.'' 1997 Jun 1;79(11):2200-8.
* Bjaalie JG, Sudbø J, Brodal P. Corticopontine terminal fibres form small scale clusters and large scale lamellae in the cat. ''Neuroreport''. 1997 May 6;8(7):1651-5.
</div>